This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...

You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...

NICE has recommended Wegovy® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse ...

Durability through 156 weeks favored semaglutide for HbA1c (−0.47%), weight (−3.26%), systolic BP (−1.83 mm Hg), and pulse ...

Oral semaglutide improved multiple cardiometabolic metrics among adults with type 2 diabetes at high risk for atherosclerotic ...

New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the type 2 diabetes and weight loss ...

The NHS has announced it will make the life-changing jab available to an additional 1.2m people as a health prevention measure - who will qualify ...

‘Major turning point’ as weight loss drugs to be prescribed to more NHS patients - Wegovy can now be prescribed for weight ...

More than a million patients who have had a heart attack or stroke and are overweight will now be eligible for weight loss ...

Some GLP-1 receptor agonists, particularly semaglutide, reduced the risk for worsening mental health in people with anxiety ...

Semaglutide is set to be offered to more than one million people with cardiovascular disease on the NHS in coming months.